European Medicines Agency updated the event page, Protection of personal data and commercially confidential information (CCI) for documents uploaded and published in the Clinical Trials Information System (CTIS): Workshop on draft guidance over the What’s New Section on September 12, 2022, by adding the summary and presentation of the sessions held on July 14, 2022:
- Event summary – Workshop on the guidance on the protection of personal data and CCI in documents submitted or uploaded via CTIS
- Presentation – Session 1.a: Key functionalities to protect personal data and CCI in CTIS
- Presentation – Session 1.b: Users’ feedback on CTIS use
- Presentation – Session 1.c: Protection of personal data and CCI for documents uploaded for CTIS
- Presentation – Session 1.d: EMA personal data CCI documents workshop
- Presentation – Session 1.e: Use of deferrals in CTIS, feedback from Member States
- Presentation – Session 2.a: Personal data protection principles governing CTIS
- Presentation – Session 2.b: Protection of Personal data and CCI for documents uploaded and published via CTIS
- Presentation – Session 2.c: Protection of Personal Data and CCI for documents uploaded and published via CTIS
- Presentation – Session 3.a: Main principles for CCI in the CTIS
- Presentation – Session 3.b: Protection of Personal Data and CCI for documents uploaded and published via CTIS